David Y. Liu
No más puestos en curso
Fortuna: 4 M $ al 31/03/2024
Perfil
David Y.
Liu was the founder of Trenovus, Inc. (founded in 2010) where he held the title of Chief Operating Officer from 2010 to 2012.
He previously worked at Scios, Inc. from 1992 to 2002 as Director-Inflammation Research and at FibroGen, Inc. from 2002 to 2010 as Vice President-Research.
Dr. Liu also worked at Harvard Medical School from 1976 to 1986 as Assistant Professor-Medicine Department.
He is currently the Chief Research & Development Strategy Officer at Protagonist Therapeutics, Inc. (since 2013).
Dr. Liu holds a doctorate degree from Michigan State University and an undergraduate degree from The University of Chicago.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
15/03/2023 | 144 687 ( 0.25% ) | 4 M $ | 31/03/2024 |
Antiguos cargos conocidos de David Y. Liu.
Empresas | Cargo | Fin |
---|---|---|
PROTAGONIST THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2023 |
Trenovus, Inc. | Founder | 01/01/2012 |
FIBROGEN, INC. | Chief Tech/Sci/R&D Officer | 01/01/2010 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Corporate Officer/Principal | 01/01/2002 |
Harvard Medical School | Corporate Officer/Principal | 01/01/1986 |
Formación de David Y. Liu.
Michigan State University | Doctorate Degree |
The University of Chicago | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
FIBROGEN, INC. | Health Technology |
PROTAGONIST THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
Trenovus, Inc. |
- Bolsa de valores
- Insiders
- David Y. Liu